Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease

Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28. Linkage and disease segregation is explained by a missense mutation c.3614G>A (p.Arg1205His) in eukaryotic translation initiation factor 4-gamma (EIF4G1). Su...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of human genetics Vol. 89; no. 3; pp. 398 - 406
Main Authors Chartier-Harlin, Marie-Christine, Dachsel, Justus C., Vilariño-Güell, Carles, Lincoln, Sarah J., Leprêtre, Frédéric, Hulihan, Mary M., Kachergus, Jennifer, Milnerwood, Austen J., Tapia, Lucia, Song, Mee-Sook, Le Rhun, Emilie, Mutez, Eugénie, Larvor, Lydie, Duflot, Aurélie, Vanbesien-Mailliot, Christel, Kreisler, Alexandre, Ross, Owen A., Nishioka, Kenya, Soto-Ortolaza, Alexandra I., Cobb, Stephanie A., Melrose, Heather L., Behrouz, Bahareh, Keeling, Brett H., Bacon, Justin A., Hentati, Emna, Williams, Lindsey, Yanagiya, Akiko, Sonenberg, Nahum, Lockhart, Paul J., Zubair, Abba C., Uitti, Ryan J., Aasly, Jan O., Krygowska-Wajs, Anna, Opala, Grzegorz, Wszolek, Zbigniew K., Frigerio, Roberta, Maraganore, Demetrius M., Gosal, David, Lynch, Tim, Hutchinson, Michael, Bentivoglio, Anna Rita, Valente, Enza Maria, Nichols, William C., Pankratz, Nathan, Foroud, Tatiana, Gibson, Rachel A., Hentati, Faycal, Dickson, Dennis W., Destée, Alain, Farrer, Matthew J.
Format Journal Article
LanguageEnglish
Published Cambridge, MA Elsevier Inc 09.09.2011
Cell Press
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28. Linkage and disease segregation is explained by a missense mutation c.3614G>A (p.Arg1205His) in eukaryotic translation initiation factor 4-gamma (EIF4G1). Subsequent sequence and genotype analysis identified EIF4G1 c.1505C>T (p.Ala502Val), c.2056G>T (p.Gly686Cys), c.3490A>C (p.Ser1164Arg), c.3589C>T (p.Arg1197Trp) and c.3614G>A (p.Arg1205His) substitutions in affected subjects with familial parkinsonism and idiopathic Lewy body disease but not in control subjects. Despite different countries of origin, persons with EIF4G1 c.1505C>T (p.Ala502Val) or c.3614G>A (p.Arg1205His) mutations appear to share haplotypes consistent with ancestral founders. eIF4G1 p.Ala502Val and p.Arg1205His disrupt eIF4E or eIF3e binding, although the wild-type protein does not, and render mutant cells more vulnerable to reactive oxidative species. EIF4G1 mutations implicate mRNA translation initiation in familial parkinsonism and highlight a convergent pathway for monogenic, toxin and perhaps virally-induced Parkinson disease.
AbstractList Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28. Linkage and disease segregation is explained by a missense mutation c.3614G>A (p.Arg1205His) in eukaryotic translation initiation factor 4-gamma (EIF4G1). Subsequent sequence and genotype analysis identified EIF4G1 c.1505C>T (p.Ala502Val), c.2056G>T (p.Gly686Cys), c.3490A>C (p.Ser1164Arg), c.3589C>T (p.Arg1197Trp) and c.3614G>A (p.Arg1205His) substitutions in affected subjects with familial parkinsonism and idiopathic Lewy body disease but not in control subjects. Despite different countries of origin, persons with EIF4G1 c.1505C>T (p.Ala502Val) or c.3614G>A (p.Arg1205His) mutations appear to share haplotypes consistent with ancestral founders. eIF4G1 p.Ala502Val and p.Arg1205His disrupt eIF4E or eIF3e binding, although the wild-type protein does not, and render mutant cells more vulnerable to reactive oxidative species. EIF4G1 mutations implicate mRNA translation initiation in familial parkinsonism and highlight a convergent pathway for monogenic, toxin and perhaps virally-induced Parkinson disease.Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28. Linkage and disease segregation is explained by a missense mutation c.3614G>A (p.Arg1205His) in eukaryotic translation initiation factor 4-gamma (EIF4G1). Subsequent sequence and genotype analysis identified EIF4G1 c.1505C>T (p.Ala502Val), c.2056G>T (p.Gly686Cys), c.3490A>C (p.Ser1164Arg), c.3589C>T (p.Arg1197Trp) and c.3614G>A (p.Arg1205His) substitutions in affected subjects with familial parkinsonism and idiopathic Lewy body disease but not in control subjects. Despite different countries of origin, persons with EIF4G1 c.1505C>T (p.Ala502Val) or c.3614G>A (p.Arg1205His) mutations appear to share haplotypes consistent with ancestral founders. eIF4G1 p.Ala502Val and p.Arg1205His disrupt eIF4E or eIF3e binding, although the wild-type protein does not, and render mutant cells more vulnerable to reactive oxidative species. EIF4G1 mutations implicate mRNA translation initiation in familial parkinsonism and highlight a convergent pathway for monogenic, toxin and perhaps virally-induced Parkinson disease.
Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28. Linkage and disease segregation is explained by a missense mutation c.3614G>A (p.Arg1205His) in eukaryotic translation initiation factor 4-gamma ( EIF4G1 ). Subsequent sequence and genotype analysis identified EIF4G1 c.1505C>T (p.Ala502Val), c.2056G>T (p.Gly686Cys), c.3490A>C (p.Ser1164Arg), c.3589C>T (p.Arg1197Trp) and c.3614G>A (p.Arg1205His) substitutions in affected subjects with familial parkinsonism and idiopathic Lewy body disease but not in control subjects. Despite different countries of origin, persons with EIF4G1 c.1505C>T (p.Ala502Val) or c.3614G>A (p.Arg1205His) mutations appear to share haplotypes consistent with ancestral founders. eIF4G1 p.Ala502Val and p.Arg1205His disrupt eIF4E or eIF3e binding, although the wild-type protein does not, and render mutant cells more vulnerable to reactive oxidative species. EIF4G1 mutations implicate mRNA translation initiation in familial parkinsonism and highlight a convergent pathway for monogenic, toxin and perhaps virally-induced Parkinson disease.
Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28. Linkage and disease segregation is explained by a missense mutation c.3614G>A (p.Arg1205His) in eukaryotic translation initiation factor 4-gamma (EIF4G1). Subsequent sequence and genotype analysis identified EIF4G1 c.1505C>T (p.Ala502Val), c.2056G>T (p.Gly686Cys), c.3490A>C (p.Ser1164Arg), c.3589C>T (p.Arg1197Trp) and c.3614G>A (p.Arg1205His) substitutions in affected subjects with familial parkinsonism and idiopathic Lewy body disease but not in control subjects. Despite different countries of origin, persons with EIF4G1 c.1505C>T (p.Ala502Val) or c.3614G>A (p.Arg1205His) mutations appear to share haplotypes consistent with ancestral founders. eIF4G1 p.Ala502Val and p.Arg1205His disrupt eIF4E or eIF3e binding, although the wild-type protein does not, and render mutant cells more vulnerable to reactive oxidative species. EIF4G1 mutations implicate mRNA translation initiation in familial parkinsonism and highlight a convergent pathway for monogenic, toxin and perhaps virally-induced Parkinson disease.
Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28. Linkage and disease segregation is explained by a missense mutation c.3614G>A (p.Arg1205His) in eukaryotic translation initiation factor 4-gamma (EIF4G1). Subsequent sequence and genotype analysis identified EIF4G1 c.1505C>T (p.Ala502Val), c.2056G>T (p.Gly686Cys), c.3490A>C (p.Ser1164Arg), c.3589C>T (p.Arg1197Trp) and c.3614G>A (p.Arg1205His) substitutions in affected subjects with familial parkinsonism and idiopathic Lewy body disease but not in control subjects. Despite different countries of origin, persons with EIF4G1 c.1505C>T (p.Ala502Val) or c.3614G>A (p.Arg1205His) mutations appear to share haplotypes consistent with ancestral founders. eIF4G1 p.Ala502Val and p.Arg1205His disrupt eIF4E or eIF3e binding, although the wild-type protein does not, and render mutant cells more vulnerable to reactive oxidative species. EIF4G1 mutations implicate mRNA translation initiation in familial parkinsonism and highlight a convergent pathway for monogenic, toxin and perhaps virally-induced Parkinson disease. [PUBLICATION ABSTRACT]
Author Yanagiya, Akiko
Ross, Owen A.
Maraganore, Demetrius M.
Lockhart, Paul J.
Aasly, Jan O.
Wszolek, Zbigniew K.
Dachsel, Justus C.
Krygowska-Wajs, Anna
Hentati, Faycal
Hentati, Emna
Williams, Lindsey
Vanbesien-Mailliot, Christel
Vilariño-Güell, Carles
Song, Mee-Sook
Uitti, Ryan J.
Kreisler, Alexandre
Hutchinson, Michael
Nichols, William C.
Zubair, Abba C.
Nishioka, Kenya
Frigerio, Roberta
Valente, Enza Maria
Gosal, David
Keeling, Brett H.
Kachergus, Jennifer
Duflot, Aurélie
Behrouz, Bahareh
Gibson, Rachel A.
Dickson, Dennis W.
Leprêtre, Frédéric
Foroud, Tatiana
Tapia, Lucia
Sonenberg, Nahum
Farrer, Matthew J.
Lynch, Tim
Bentivoglio, Anna Rita
Opala, Grzegorz
Lincoln, Sarah J.
Melrose, Heather L.
Mutez, Eugénie
Milnerwood, Austen J.
Le Rhun, Emilie
Hulihan, Mary M.
Larvor, Lydie
Soto-Ortolaza, Alexandra I.
Destée, Alain
Bacon, Justin A.
Pankratz, Nathan
Cobb, Stephanie A.
Chartier-Harlin, Marie-Christine
AuthorAffiliation 5 Centre Hospitalier Régional Universitaire de Lille(CHRU), Department of Neurology and Movement Disorders, F-59000 Lille, France
2 Institut National de la Santé et de la Recherche Médicale (Inserm) UMR837, Institut de Recherches sur le Cancer de Lille (IRCL), Place de Verdun, 59045 Lille Cedex, IFR114 IMPRT F-59000 Lille, France
3 Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
8 Bruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Parkville, Victoria 3052, Australia
9 Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL 32224, USA
16 Department of Neurology, St Vincent's University Hospital, Dublin 4, Ireland
1 Université Lille Nord de France, F-59000 Lille, France
20 Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA
14 Dublin Neurological Institute at the Mater Misericordiae University Hospital, Dublin 7, Ireland
21 Department of Medical and Molec
AuthorAffiliation_xml – name: 3 Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– name: 9 Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL 32224, USA
– name: 18 Mendel Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013 Italy
– name: 6 Université des Sciences et Technologies de Lille (USTL), Department of Neurosciences, Villeneuve d'Ascq, F-59655 France
– name: 2 Institut National de la Santé et de la Recherche Médicale (Inserm) UMR837, Institut de Recherches sur le Cancer de Lille (IRCL), Place de Verdun, 59045 Lille Cedex, IFR114 IMPRT F-59000 Lille, France
– name: 10 Department of Neurology, St. Olav's Hospital, Trondheim N-7006, Norway
– name: 14 Dublin Neurological Institute at the Mater Misericordiae University Hospital, Dublin 7, Ireland
– name: 1 Université Lille Nord de France, F-59000 Lille, France
– name: 16 Department of Neurology, St Vincent's University Hospital, Dublin 4, Ireland
– name: 11 Department of Neurology, Collegium Medicum, Jagiellonian University, Krakow 31-358, Poland
– name: 15 Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland
– name: 19 Department of Medical and Surgical Pediatric Sciences, University of Messina, Messina, 98124 Italy
– name: 12 Department of Neurology, Aging, Degenerative and Cerebrovascular Disorders, Medical University of Silesia, Katowice 40-055, Poland
– name: 7 Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Montreal, Quebec H3A 3R1, Canada
– name: 4 Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada
– name: 5 Centre Hospitalier Régional Universitaire de Lille(CHRU), Department of Neurology and Movement Disorders, F-59000 Lille, France
– name: 8 Bruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Parkville, Victoria 3052, Australia
– name: 20 Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA
– name: 21 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
– name: 22 GlaxoSmithKline Pharmaceuticals, Research and Development, Harlow, Greenford, Hammersmith CM19 5AW, UK
– name: 23 Service de Neurologie, Institut National de Neurologie, 1007 La Rabta, Tunis, Tunisia
– name: 17 Institute of Neurology, Catholic University, Rome 00168, Italy
– name: 13 Department of Neurology, Mayo Clinic, Rochester, MN 55909, USA
Author_xml – sequence: 1
  givenname: Marie-Christine
  surname: Chartier-Harlin
  fullname: Chartier-Harlin, Marie-Christine
  organization: Université Lille Nord de France, F-59000 Lille, France
– sequence: 2
  givenname: Justus C.
  surname: Dachsel
  fullname: Dachsel, Justus C.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 3
  givenname: Carles
  surname: Vilariño-Güell
  fullname: Vilariño-Güell, Carles
  organization: Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada
– sequence: 4
  givenname: Sarah J.
  surname: Lincoln
  fullname: Lincoln, Sarah J.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 5
  givenname: Frédéric
  surname: Leprêtre
  fullname: Leprêtre, Frédéric
  organization: Université Lille Nord de France, F-59000 Lille, France
– sequence: 6
  givenname: Mary M.
  surname: Hulihan
  fullname: Hulihan, Mary M.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 7
  givenname: Jennifer
  surname: Kachergus
  fullname: Kachergus, Jennifer
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 8
  givenname: Austen J.
  surname: Milnerwood
  fullname: Milnerwood, Austen J.
  organization: Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada
– sequence: 9
  givenname: Lucia
  surname: Tapia
  fullname: Tapia, Lucia
  organization: Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada
– sequence: 10
  givenname: Mee-Sook
  surname: Song
  fullname: Song, Mee-Sook
  organization: Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada
– sequence: 11
  givenname: Emilie
  surname: Le Rhun
  fullname: Le Rhun, Emilie
  organization: Centre Hospitalier Régional Universitaire de Lille(CHRU), Department of Neurology and Movement Disorders, F-59000 Lille, France
– sequence: 12
  givenname: Eugénie
  surname: Mutez
  fullname: Mutez, Eugénie
  organization: Université Lille Nord de France, F-59000 Lille, France
– sequence: 13
  givenname: Lydie
  surname: Larvor
  fullname: Larvor, Lydie
  organization: Université Lille Nord de France, F-59000 Lille, France
– sequence: 14
  givenname: Aurélie
  surname: Duflot
  fullname: Duflot, Aurélie
  organization: Université Lille Nord de France, F-59000 Lille, France
– sequence: 15
  givenname: Christel
  surname: Vanbesien-Mailliot
  fullname: Vanbesien-Mailliot, Christel
  organization: Université Lille Nord de France, F-59000 Lille, France
– sequence: 16
  givenname: Alexandre
  surname: Kreisler
  fullname: Kreisler, Alexandre
  organization: Université Lille Nord de France, F-59000 Lille, France
– sequence: 17
  givenname: Owen A.
  surname: Ross
  fullname: Ross, Owen A.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 18
  givenname: Kenya
  surname: Nishioka
  fullname: Nishioka, Kenya
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 19
  givenname: Alexandra I.
  surname: Soto-Ortolaza
  fullname: Soto-Ortolaza, Alexandra I.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 20
  givenname: Stephanie A.
  surname: Cobb
  fullname: Cobb, Stephanie A.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 21
  givenname: Heather L.
  surname: Melrose
  fullname: Melrose, Heather L.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 22
  givenname: Bahareh
  surname: Behrouz
  fullname: Behrouz, Bahareh
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 23
  givenname: Brett H.
  surname: Keeling
  fullname: Keeling, Brett H.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 24
  givenname: Justin A.
  surname: Bacon
  fullname: Bacon, Justin A.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 25
  givenname: Emna
  surname: Hentati
  fullname: Hentati, Emna
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 26
  givenname: Lindsey
  surname: Williams
  fullname: Williams, Lindsey
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 27
  givenname: Akiko
  surname: Yanagiya
  fullname: Yanagiya, Akiko
  organization: Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Montreal, Quebec H3A 3R1, Canada
– sequence: 28
  givenname: Nahum
  surname: Sonenberg
  fullname: Sonenberg, Nahum
  organization: Department of Biochemistry and Goodman Cancer Research Centre, McGill University, Montreal, Quebec H3A 3R1, Canada
– sequence: 29
  givenname: Paul J.
  surname: Lockhart
  fullname: Lockhart, Paul J.
  organization: Bruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Parkville, Victoria 3052, Australia
– sequence: 30
  givenname: Abba C.
  surname: Zubair
  fullname: Zubair, Abba C.
  organization: Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 31
  givenname: Ryan J.
  surname: Uitti
  fullname: Uitti, Ryan J.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 32
  givenname: Jan O.
  surname: Aasly
  fullname: Aasly, Jan O.
  organization: Department of Neurology, St. Olav's Hospital, Trondheim N-7006, Norway
– sequence: 33
  givenname: Anna
  surname: Krygowska-Wajs
  fullname: Krygowska-Wajs, Anna
  organization: Department of Neurology, Collegium Medicum, Jagiellonian University, Krakow 31-358, Poland
– sequence: 34
  givenname: Grzegorz
  surname: Opala
  fullname: Opala, Grzegorz
  organization: Department of Neurology, Aging, Degenerative and Cerebrovascular Disorders, Medical University of Silesia, Katowice 40-055, Poland
– sequence: 35
  givenname: Zbigniew K.
  surname: Wszolek
  fullname: Wszolek, Zbigniew K.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 36
  givenname: Roberta
  surname: Frigerio
  fullname: Frigerio, Roberta
  organization: Department of Neurology, Mayo Clinic, Rochester, MN 55909, USA
– sequence: 37
  givenname: Demetrius M.
  surname: Maraganore
  fullname: Maraganore, Demetrius M.
  organization: Department of Neurology, Mayo Clinic, Rochester, MN 55909, USA
– sequence: 38
  givenname: David
  surname: Gosal
  fullname: Gosal, David
  organization: Dublin Neurological Institute at the Mater Misericordiae University Hospital, Dublin 7, Ireland
– sequence: 39
  givenname: Tim
  surname: Lynch
  fullname: Lynch, Tim
  organization: Dublin Neurological Institute at the Mater Misericordiae University Hospital, Dublin 7, Ireland
– sequence: 40
  givenname: Michael
  surname: Hutchinson
  fullname: Hutchinson, Michael
  organization: Department of Neurology, St Vincent's University Hospital, Dublin 4, Ireland
– sequence: 41
  givenname: Anna Rita
  surname: Bentivoglio
  fullname: Bentivoglio, Anna Rita
  organization: Institute of Neurology, Catholic University, Rome 00168, Italy
– sequence: 42
  givenname: Enza Maria
  surname: Valente
  fullname: Valente, Enza Maria
  organization: Mendel Laboratory, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013 Italy
– sequence: 43
  givenname: William C.
  surname: Nichols
  fullname: Nichols, William C.
  organization: Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA
– sequence: 44
  givenname: Nathan
  surname: Pankratz
  fullname: Pankratz, Nathan
  organization: Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
– sequence: 45
  givenname: Tatiana
  surname: Foroud
  fullname: Foroud, Tatiana
  organization: Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
– sequence: 46
  givenname: Rachel A.
  surname: Gibson
  fullname: Gibson, Rachel A.
  organization: GlaxoSmithKline Pharmaceuticals, Research and Development, Harlow, Greenford, Hammersmith CM19 5AW, UK
– sequence: 47
  givenname: Faycal
  surname: Hentati
  fullname: Hentati, Faycal
  organization: Service de Neurologie, Institut National de Neurologie, 1007 La Rabta, Tunis, Tunisia
– sequence: 48
  givenname: Dennis W.
  surname: Dickson
  fullname: Dickson, Dennis W.
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
– sequence: 49
  givenname: Alain
  surname: Destée
  fullname: Destée, Alain
  organization: Université Lille Nord de France, F-59000 Lille, France
– sequence: 50
  givenname: Matthew J.
  surname: Farrer
  fullname: Farrer, Matthew J.
  email: mfarrer@can.ubc.ca
  organization: Departments of Neurology and Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24524141$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21907011$$D View this record in MEDLINE/PubMed
BookMark eNqFkl9rFDEUxYNU7Lb6BXyQQRCfZrzJZCYJiCBtty5U9GHfw51Mps06m9RkpuC3N-tu_dOH-hTC_Z3DTc45IUc-eEvISwoVBdq-21S4ubmuGFBagawA1BOyoE0tyraF5ogsAICViilxTE5S2kAGJdTPyDGjCkS-Lcj5OqJPI04u-GLl3eRwCrG4WC35JS0-z9OvSSqcL5a4daPDsfiK8ZvzKQvOXbKY7HPydMAx2ReH85Sslxfrs0_l1ZfL1dnHq9K0oKay74YWu5pDDb1Qddf0Tc_RsqFjHNsOe2qFRGVr0aERlhsuAKSSUqnaqr4-JR_2trdzt7W9sX6KOOrb6LYYf-iATv878e5GX4c7XdNWSdZkg7cHgxi-zzZNeuuSseOI3oY5aUVByJZR8V8y70SFkIpl8vUDchPm6PM36DyGRrWUZ-jV35v_Xvk-hwy8OQCYDI5DDsW49IfjDeOU7zi550wMKUU7aOP2EeUHu1FT0Ltq6I3eVUPvqqFB6lyNLGUPpPfuj4re70U2x3rnbNTJOOuN7V20ZtJ9cI_JfwIbONES
CODEN AJHGAG
CitedBy_id crossref_primary_10_1016_j_neurobiolaging_2013_04_025
crossref_primary_10_1111_jnc_12949
crossref_primary_10_1371_journal_pgen_1002548
crossref_primary_10_1016_j_baga_2015_09_001
crossref_primary_10_17352_ojpdt_000005
crossref_primary_10_1002_mds_27193
crossref_primary_10_1097_MD_0000000000030079
crossref_primary_10_1016_j_neurobiolaging_2014_04_020
crossref_primary_10_1021_acschemneuro_8b00520
crossref_primary_10_1016_j_tig_2015_01_004
crossref_primary_10_1016_j_mad_2016_05_002
crossref_primary_10_1038_s41392_024_01749_9
crossref_primary_10_1007_s00401_019_02099_5
crossref_primary_10_1136_jmedgenet_2014_102570
crossref_primary_10_3389_fnins_2018_00612
crossref_primary_10_3389_fnmol_2021_660208
crossref_primary_10_3390_brainsci8120222
crossref_primary_10_3892_etm_2024_12494
crossref_primary_10_1016_j_jmb_2018_05_009
crossref_primary_10_1007_s00415_013_6970_7
crossref_primary_10_1038_s10038_022_01058_5
crossref_primary_10_3109_01677063_2011_627072
crossref_primary_10_3389_fnmol_2017_00224
crossref_primary_10_1016_j_bbrc_2014_07_098
crossref_primary_10_1016_j_neulet_2013_09_037
crossref_primary_10_2217_fnl_12_59
crossref_primary_10_1007_s13530_024_00238_4
crossref_primary_10_1016_j_parkreldis_2013_01_020
crossref_primary_10_1016_j_jmb_2023_168144
crossref_primary_10_1002_mgg3_807
crossref_primary_10_1016_j_drudis_2019_04_003
crossref_primary_10_1016_S0140_6736_14_61393_3
crossref_primary_10_3390_ijms25042393
crossref_primary_10_1016_S1634_7072_18_41584_X
crossref_primary_10_1172_JCI66029
crossref_primary_10_1016_j_neurobiolaging_2014_12_030
crossref_primary_10_1016_S1353_8020_11_70005_0
crossref_primary_10_1002_ajmg_a_63230
crossref_primary_10_1016_j_mcp_2019_101471
crossref_primary_10_3390_life11050432
crossref_primary_10_1016_j_parkreldis_2016_12_001
crossref_primary_10_1124_pharmrev_120_000189
crossref_primary_10_1007_s00401_012_1013_5
crossref_primary_10_1007_s00401_012_1059_4
crossref_primary_10_1101_gad_236752_113
crossref_primary_10_1016_j_bbadis_2013_12_014
crossref_primary_10_1007_s13760_020_01473_5
crossref_primary_10_3389_fnagi_2014_00089
crossref_primary_10_1042_BST20130131
crossref_primary_10_1186_s13024_019_0329_1
crossref_primary_10_1016_j_neurobiolaging_2012_05_006
crossref_primary_10_1016_j_trci_2018_06_005
crossref_primary_10_1016_j_neuron_2014_11_027
crossref_primary_10_1016_j_gendis_2021_12_015
crossref_primary_10_1016_j_nbd_2020_105056
crossref_primary_10_1038_s41467_021_21053_2
crossref_primary_10_1371_journal_pone_0085510
crossref_primary_10_1002_mds_24896
crossref_primary_10_1111_cge_13124
crossref_primary_10_1097_MD_0000000000000836
crossref_primary_10_1007_s12035_013_8489_4
crossref_primary_10_1016_j_neuro_2014_08_006
crossref_primary_10_1016_j_neurobiolaging_2013_08_023
crossref_primary_10_1371_journal_pone_0128651
crossref_primary_10_1186_1471_2377_13_38
crossref_primary_10_1016_j_praneu_2012_12_002
crossref_primary_10_3390_ijms25021299
crossref_primary_10_1038_s41392_023_01353_3
crossref_primary_10_1007_s10571_013_9933_8
crossref_primary_10_1371_journal_pone_0163447
crossref_primary_10_3390_cells11223538
crossref_primary_10_1038_nrneurol_2013_132
crossref_primary_10_1097_MD_0000000000010234
crossref_primary_10_1212_WNL_0b013e318287289c
crossref_primary_10_1016_j_trprot_2014_08_001
crossref_primary_10_1111_ene_12051
crossref_primary_10_1016_j_bbrc_2014_06_028
crossref_primary_10_1016_j_neulet_2016_06_054
crossref_primary_10_3233_JPD_150738
crossref_primary_10_2337_db20_0057
crossref_primary_10_1007_s13311_014_0284_z
crossref_primary_10_1186_gm566
crossref_primary_10_1002_mds_26428
crossref_primary_10_1111_jnc_14471
crossref_primary_10_3390_cells12040621
crossref_primary_10_3390_biom9030088
crossref_primary_10_1186_s13024_019_0306_8
crossref_primary_10_1016_j_neurobiolaging_2015_04_017
crossref_primary_10_1093_database_baae085
crossref_primary_10_3389_fnagi_2022_1002777
crossref_primary_10_3389_fncel_2017_00212
crossref_primary_10_1177_1756285613493469
crossref_primary_10_1038_s41580_018_0034_x
crossref_primary_10_1080_21678421_2021_1962355
crossref_primary_10_1016_j_brainres_2014_03_003
crossref_primary_10_1007_s12041_019_1139_5
crossref_primary_10_1016_j_neurobiolaging_2014_07_039
crossref_primary_10_1038_nrneurol_2012_148
crossref_primary_10_1016_j_neulet_2022_136880
crossref_primary_10_1038_nrm3565
crossref_primary_10_1093_hmg_ddu086
crossref_primary_10_1002_ijch_201500071
crossref_primary_10_1016_j_arr_2017_12_007
crossref_primary_10_3389_fnins_2022_817713
crossref_primary_10_1016_j_mcp_2016_11_001
crossref_primary_10_1111_ane_12616
crossref_primary_10_3389_fneur_2018_00228
crossref_primary_10_1002_mds_25249
crossref_primary_10_1016_j_jneuroim_2013_11_006
crossref_primary_10_1212_WNL_0b013e31828727d4
crossref_primary_10_1007_s00415_013_7003_2
crossref_primary_10_1016_j_cell_2022_05_008
crossref_primary_10_1016_j_febslet_2015_10_002
crossref_primary_10_1016_j_neulet_2015_08_020
crossref_primary_10_1186_s40035_019_0145_0
crossref_primary_10_1016_j_npep_2022_102283
crossref_primary_10_1038_ng_3589
crossref_primary_10_1017_thg_2023_14
crossref_primary_10_5694_mja17_01254
crossref_primary_10_1248_bpb_b17_00663
crossref_primary_10_1016_j_molmed_2015_05_004
crossref_primary_10_1089_scd_2017_0286
crossref_primary_10_1016_j_ajhg_2024_12_019
crossref_primary_10_3390_life12010121
crossref_primary_10_1016_j_ygeno_2020_04_025
crossref_primary_10_1016_S1353_8020_13_70009_9
crossref_primary_10_3389_fpsyt_2016_00089
crossref_primary_10_1212_NXG_0000000000000070
crossref_primary_10_1002_mdc3_12000
crossref_primary_10_1007_s00439_013_1287_2
crossref_primary_10_1016_S1353_8020_11_70022_0
crossref_primary_10_1097_WCO_0b013e3283547627
crossref_primary_10_1016_j_arr_2013_12_008
crossref_primary_10_1002_wrna_1814
crossref_primary_10_1007_s00401_016_1590_9
crossref_primary_10_1016_j_neurobiolaging_2012_11_003
crossref_primary_10_54005_geneltip_1337447
crossref_primary_10_1111_ane_12563
crossref_primary_10_1016_j_phrs_2021_105535
crossref_primary_10_1016_j_jfma_2015_07_020
crossref_primary_10_1021_acs_jproteome_0c00747
crossref_primary_10_1007_s10048_013_0383_8
crossref_primary_10_1016_j_neuron_2016_05_040
crossref_primary_10_1016_j_neulet_2012_04_033
crossref_primary_10_1093_hmg_ddt570
crossref_primary_10_1016_j_neurobiolaging_2016_05_016
crossref_primary_10_3389_fnins_2016_00162
crossref_primary_10_1016_S0035_3787_12_70026_7
crossref_primary_10_1007_s10545_014_9723_6
crossref_primary_10_1042_BST20120093
crossref_primary_10_3390_ijms21155301
crossref_primary_10_1002_humu_22803
crossref_primary_10_1016_j_cmet_2014_12_007
crossref_primary_10_3390_genes12030430
crossref_primary_10_1007_s10048_012_0334_9
crossref_primary_10_1016_j_neurol_2018_08_004
crossref_primary_10_1111_cge_14019
crossref_primary_10_1523_JNEUROSCI_2286_13_2014
crossref_primary_10_1016_S1353_8020_13_70011_7
crossref_primary_10_1111_ane_12397
crossref_primary_10_1016_j_cell_2014_01_064
crossref_primary_10_1007_s10571_018_0587_4
crossref_primary_10_1016_j_pharmthera_2013_01_013
crossref_primary_10_1007_s10048_016_0494_0
crossref_primary_10_1002_humu_23218
crossref_primary_10_1016_j_neurobiolaging_2020_10_019
crossref_primary_10_1136_jmedgenet_2015_103616
crossref_primary_10_1016_j_nbd_2023_106337
crossref_primary_10_5483_BMBRep_2019_52_4_204
crossref_primary_10_1016_j_mcna_2019_08_003
crossref_primary_10_1371_journal_pone_0116473
crossref_primary_10_1016_j_neulet_2013_02_056
crossref_primary_10_1155_2016_6734678
crossref_primary_10_1186_1741_7015_10_20
crossref_primary_10_1007_s00441_017_2768_8
crossref_primary_10_1186_s12864_022_08645_y
crossref_primary_10_1186_s40478_016_0402_8
crossref_primary_10_12688_f1000research_11820_1
crossref_primary_10_1016_j_nbd_2013_11_007
crossref_primary_10_1093_jnen_nlaf001
crossref_primary_10_1016_j_gde_2017_01_013
crossref_primary_10_1155_2016_6465793
crossref_primary_10_1371_journal_pone_0102909
crossref_primary_10_1016_j_parkreldis_2014_03_004
crossref_primary_10_1097_WCO_0000000000001167
crossref_primary_10_1016_j_cels_2016_12_011
crossref_primary_10_3389_fcell_2021_636506
Cites_doi 10.1038/ncb1900
10.1111/j.1749-6632.2009.04365.x
10.1038/nrg2142
10.1038/42166
10.1016/S1474-4422(09)70238-8
10.1016/j.expneurol.2009.03.006
10.1074/jbc.M605418200
10.1038/nature09191
10.1038/nrm2672
10.1126/scisignal.2000308
10.1002/1531-8257(200011)15:6<1075::AID-MDS1004>3.0.CO;2-2
10.1128/MCB.01187-08
10.1073/pnas.86.11.4175
10.1126/science.276.5321.2045
10.1038/nn.2372
10.1196/annals.1427.023
10.1159/000053366
10.1016/j.ajhg.2011.06.001
10.1016/S1474-4422(06)70471-9
10.1016/j.neuron.2010.10.014
10.1083/jcb.200710215
10.1001/archneur.56.1.33
10.1093/bioinformatics/bti024
10.1016/j.cell.2009.01.042
10.1016/S0248-4900(03)00031-5
ContentType Journal Article
Copyright 2011 The American Society of Human Genetics
2015 INIST-CNRS
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Copyright Cell Press Sep 9, 2011
2011 The American Society of Human Genetics. Published by Elsevier Ltd. All right reserved. 2011 The American Society of Human Genetics
Copyright_xml – notice: 2011 The American Society of Human Genetics
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
– notice: Copyright Cell Press Sep 9, 2011
– notice: 2011 The American Society of Human Genetics. Published by Elsevier Ltd. All right reserved. 2011 The American Society of Human Genetics
DBID 6I.
AAFTH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
7TM
7U7
8FD
C1K
FR3
K9.
NAPCQ
P64
RC3
7X8
5PM
DOI 10.1016/j.ajhg.2011.08.009
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Genetics Abstracts
Technology Research Database
Toxicology Abstracts
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Nursing & Allied Health Premium
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1537-6605
EndPage 406
ExternalDocumentID PMC3169825
2459816781
21907011
24524141
10_1016_j_ajhg_2011_08_009
S0002929711003594
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
Feature
GrantInformation_xml – fundername: NIEHS NIH HHS
  grantid: R01 ES010751
– fundername: NIEHS NIH HHS
  grantid: 2R01 ES10751
– fundername: NINDS NIH HHS
  grantid: P50 NS40256
– fundername: NINDS NIH HHS
  grantid: NS072187
– fundername: NINDS NIH HHS
  grantid: R01NS37167
– fundername: NINDS NIH HHS
  grantid: P01 NS040256
– fundername: NINDS NIH HHS
  grantid: P50 NS072187
– fundername: NINDS NIH HHS
  grantid: P50 NS040256
– fundername: NINDS NIH HHS
  grantid: R01 NS037167
GroupedDBID ---
--K
--Z
-~X
0R~
123
1~5
23M
2WC
34R
3O-
4.4
457
4G.
53G
5GY
62-
6I.
6J9
7-5
85S
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKRW
AALRI
AAUCE
AAVLU
AAWTL
AAXJY
AAXUO
ABJNI
ABMAC
ABMWF
ABOCM
ABVKL
ACGFO
ACGFS
ACGOD
ACNCT
ACPRK
ADBBV
ADEZE
ADJPV
AENEX
AEXQZ
AFRAH
AFTJW
AGCDD
AGHFR
AGKMS
AHMBA
AITUG
ALKID
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
C1A
CS3
D0L
DIK
E3Z
EBS
ECV
EJD
F5P
FCP
FDB
FEDTE
GX1
HVGLF
HYE
HZ~
IH2
IHE
IXB
JIG
KQ8
L7B
M41
NCXOZ
O-L
O9-
OK1
P2P
PQQKQ
RCE
RIG
RNS
ROL
RPM
RPZ
SES
SJN
SSZ
TN5
TR2
TWZ
UHB
UKR
UNMZH
UPT
VQA
WH7
WQ6
ZA5
ZCA
.55
.GJ
41~
AAFWJ
AAMRU
AAQXK
AAYWO
AAYXX
ABDGV
ABWVN
ACKIV
ACRPL
ACVFH
ADCNI
ADMUD
ADNMO
ADVLN
ADXHL
AEUPX
AFPUW
AGCQF
AGQPQ
AI.
AIGII
AKAPO
AKBMS
AKRWK
AKYEP
APXCP
CITATION
FA8
FGOYB
MVM
NEJ
OHT
OZT
R2-
VH1
WOQ
X7M
XOL
ZCG
ZGI
ZXP
EFKBS
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
7TM
7U7
8FD
C1K
FR3
K9.
NAPCQ
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c609t-dbf6ab34030d793b5d5d4ae2fb24a6bad1e78a9e37bac7e4c47008988993e9d3
IEDL.DBID IXB
ISSN 0002-9297
1537-6605
IngestDate Thu Aug 21 14:13:29 EDT 2025
Fri Jul 11 01:33:17 EDT 2025
Fri Jul 11 12:07:13 EDT 2025
Sun Jul 13 05:07:06 EDT 2025
Thu Apr 03 07:09:16 EDT 2025
Mon Jul 21 09:16:15 EDT 2025
Tue Jul 01 03:39:09 EDT 2025
Thu Apr 24 22:52:08 EDT 2025
Fri Feb 23 02:29:29 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Human
Nervous system diseases
Familial disease
Initiator
Central nervous system disease
Parkinson disease
Genetics
Degenerative disease
Mutation
Cerebral disorder
Extrapyramidal syndrome
Language English
License http://www.elsevier.com/open-access/userlicense/1.0
https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c609t-dbf6ab34030d793b5d5d4ae2fb24a6bad1e78a9e37bac7e4c47008988993e9d3
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
These authors contributed equally to this work
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0002929711003594
PMID 21907011
PQID 892059614
PQPubID 24320
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3169825
proquest_miscellaneous_910786217
proquest_miscellaneous_889177892
proquest_journals_892059614
pubmed_primary_21907011
pascalfrancis_primary_24524141
crossref_citationtrail_10_1016_j_ajhg_2011_08_009
crossref_primary_10_1016_j_ajhg_2011_08_009
elsevier_sciencedirect_doi_10_1016_j_ajhg_2011_08_009
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-09-09
PublicationDateYYYYMMDD 2011-09-09
PublicationDate_xml – month: 09
  year: 2011
  text: 2011-09-09
  day: 09
PublicationDecade 2010
PublicationPlace Cambridge, MA
PublicationPlace_xml – name: Cambridge, MA
– name: United States
– name: Chicago
PublicationTitle American journal of human genetics
PublicationTitleAlternate Am J Hum Genet
PublicationYear 2011
Publisher Elsevier Inc
Cell Press
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Cell Press
– name: Elsevier
References Gelb, Oliver, Gilman (bib1) 1999; 56
Ott (bib11) 1989; 86
Gehrke, Imai, Sokol, Lu (bib22) 2010; 466
LeFebvre, Korneeva, Trutschl, Cvek, Duzan, Bradley, Hershey, Rhoads (bib17) 2006; 281
Hardy (bib4) 2010; 68
de Lau, Breteler (bib3) 2006; 5
Büeler (bib7) 2009; 218
Ramírez-Valle, Braunstein, Zavadil, Formenti, Schneider (bib9) 2008; 181
Kong, Matise (bib13) 2005; 21
Prévôt, Darlix, Ohlmann (bib16) 2003; 95
Tain, Mortiboys, Tao, Ziviani, Bandmann, Whitworth (bib23) 2009; 12
Hawkes, Del Tredici, Braak (bib19) 2009; 1170
Zhou, Huang, Przedborski (bib20) 2008; 1147
Sonenberg, Hinnebusch (bib18) 2009; 136
Ma, Blenis (bib21) 2009; 10
Santini, Heiman, Greengard, Valjent, Fisone (bib25) 2009; 2
Dickson, Braak, Duda, Duyckaerts, Gasser, Halliday, Hardy, Leverenz, Del Tredici, Wszolek, Litvan (bib2) 2009; 8
Yanagiya, Svitkin, Shibata, Mikami, Imataka, Sonenberg (bib14) 2009; 29
Spillantini, Schmidt, Lee, Trojanowski, Jakes, Goedert (bib6) 1997; 388
Scheper, van der Knaap, Proud (bib24) 2007; 8
Polymeropoulos, Lavedan, Leroy, Ide, Dehejia, Dutra, Pike, Root, Rubenstein, Boyer (bib15) 1997; 276
Vilariño-Güell, Wider, Ross, Dachsel, Kachergus, Lincoln, Soto-Ortolaza, Cobb, Wilhoite, Bacon (bib5) 2011; 89
Silvera, Arju, Darvishian, Levine, Zolfaghari, Goldberg, Hochman, Formenti, Schneider (bib10) 2009; 11
Farrer, Destée, Becquet, Wavrant-De Vrièze, Mouroux, Richard, Defebvre, Lincoln, Hardy, Amouyel, Chartier-Harlin (bib8) 2000; 15
Sobel, Sengul, Weeks (bib12) 2001; 52
Vilariño-Güell (10.1016/j.ajhg.2011.08.009_bib5) 2011; 89
Scheper (10.1016/j.ajhg.2011.08.009_bib24) 2007; 8
Hardy (10.1016/j.ajhg.2011.08.009_bib4) 2010; 68
Tain (10.1016/j.ajhg.2011.08.009_bib23) 2009; 12
Spillantini (10.1016/j.ajhg.2011.08.009_bib6) 1997; 388
Yanagiya (10.1016/j.ajhg.2011.08.009_bib14) 2009; 29
Santini (10.1016/j.ajhg.2011.08.009_bib25) 2009; 2
Ramírez-Valle (10.1016/j.ajhg.2011.08.009_bib9) 2008; 181
Farrer (10.1016/j.ajhg.2011.08.009_bib8) 2000; 15
Ott (10.1016/j.ajhg.2011.08.009_bib11) 1989; 86
Dickson (10.1016/j.ajhg.2011.08.009_bib2) 2009; 8
Silvera (10.1016/j.ajhg.2011.08.009_bib10) 2009; 11
Zhou (10.1016/j.ajhg.2011.08.009_bib20) 2008; 1147
Ma (10.1016/j.ajhg.2011.08.009_bib21) 2009; 10
Sobel (10.1016/j.ajhg.2011.08.009_bib12) 2001; 52
Prévôt (10.1016/j.ajhg.2011.08.009_bib16) 2003; 95
Büeler (10.1016/j.ajhg.2011.08.009_bib7) 2009; 218
de Lau (10.1016/j.ajhg.2011.08.009_bib3) 2006; 5
Gehrke (10.1016/j.ajhg.2011.08.009_bib22) 2010; 466
Gelb (10.1016/j.ajhg.2011.08.009_bib1) 1999; 56
Sonenberg (10.1016/j.ajhg.2011.08.009_bib18) 2009; 136
Kong (10.1016/j.ajhg.2011.08.009_bib13) 2005; 21
Polymeropoulos (10.1016/j.ajhg.2011.08.009_bib15) 1997; 276
LeFebvre (10.1016/j.ajhg.2011.08.009_bib17) 2006; 281
Hawkes (10.1016/j.ajhg.2011.08.009_bib19) 2009; 1170
11588394 - Hum Hered. 2001;52(3):121-31
20671708 - Nature. 2010 Jul 29;466(7306):637-41
18426977 - J Cell Biol. 2008 Apr 21;181(2):293-307
19114555 - Mol Cell Biol. 2009 Mar;29(6):1661-9
19339977 - Nat Rev Mol Cell Biol. 2009 May;10(5):307-18
19686202 - Ann N Y Acad Sci. 2009 Jul;1170:615-22
16766523 - J Biol Chem. 2006 Aug 11;281(32):22917-32
19076434 - Ann N Y Acad Sci. 2008 Dec;1147:93-104
19622833 - Sci Signal. 2009;2(80):ra36
19303005 - Exp Neurol. 2009 Aug;218(2):235-46
12867079 - Biol Cell. 2003 May-Jun;95(3-4):141-56
16713924 - Lancet Neurol. 2006 Jun;5(6):525-35
15374870 - Bioinformatics. 2005 Feb 15;21(4):557-9
17680008 - Nat Rev Genet. 2007 Sep;8(9):711-23
2726769 - Proc Natl Acad Sci U S A. 1989 Jun;86(11):4175-8
9278044 - Nature. 1997 Aug 28;388(6645):839-40
11104189 - Mov Disord. 2000 Nov;15(6):1075-83
19239892 - Cell. 2009 Feb 20;136(4):731-45
19909913 - Lancet Neurol. 2009 Dec;8(12):1150-7
21763482 - Am J Hum Genet. 2011 Jul 15;89(1):162-7
9197268 - Science. 1997 Jun 27;276(5321):2045-7
20955928 - Neuron. 2010 Oct 21;68(2):201-6
19684592 - Nat Neurosci. 2009 Sep;12(9):1129-35
9923759 - Arch Neurol. 1999 Jan;56(1):33-9
19525934 - Nat Cell Biol. 2009 Jul;11(7):903-8
References_xml – volume: 1147
  start-page: 93
  year: 2008
  end-page: 104
  ident: bib20
  article-title: Oxidative stress in Parkinson's disease: A mechanism of pathogenic and therapeutic significance
  publication-title: Ann. N Y Acad. Sci.
– volume: 12
  start-page: 1129
  year: 2009
  end-page: 1135
  ident: bib23
  article-title: Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
  publication-title: Nat. Neurosci.
– volume: 15
  start-page: 1075
  year: 2000
  end-page: 1083
  ident: bib8
  article-title: Linkage exclusion in French families with probable Parkinson' s disease
  publication-title: Mov. Disord.
– volume: 52
  start-page: 121
  year: 2001
  end-page: 131
  ident: bib12
  article-title: Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees
  publication-title: Hum. Hered.
– volume: 21
  start-page: 557
  year: 2005
  end-page: 559
  ident: bib13
  article-title: MAP-O-MAT: Internet-based linkage mapping
  publication-title: Bioinformatics
– volume: 68
  start-page: 201
  year: 2010
  end-page: 206
  ident: bib4
  article-title: Genetic analysis of pathways to Parkinson disease
  publication-title: Neuron
– volume: 1170
  start-page: 615
  year: 2009
  end-page: 622
  ident: bib19
  article-title: Parkinson's disease: The dual hit theory revisited
  publication-title: Ann. N Y Acad. Sci.
– volume: 466
  start-page: 637
  year: 2010
  end-page: 641
  ident: bib22
  article-title: Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
  publication-title: Nature
– volume: 10
  start-page: 307
  year: 2009
  end-page: 318
  ident: bib21
  article-title: Molecular mechanisms of mTOR-mediated translational control
  publication-title: Nature reviews
– volume: 8
  start-page: 1150
  year: 2009
  end-page: 1157
  ident: bib2
  article-title: Neuropathological assessment of Parkinson's disease: Refining the diagnostic criteria
  publication-title: Lancet Neurol.
– volume: 11
  start-page: 903
  year: 2009
  end-page: 908
  ident: bib10
  article-title: Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer
  publication-title: Nat. Cell Biol.
– volume: 2
  start-page: ra36
  year: 2009
  ident: bib25
  article-title: Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia
  publication-title: Sci. Signal.
– volume: 276
  start-page: 2045
  year: 1997
  end-page: 2047
  ident: bib15
  article-title: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
  publication-title: Science
– volume: 56
  start-page: 33
  year: 1999
  end-page: 39
  ident: bib1
  article-title: Diagnostic criteria for Parkinson disease
  publication-title: Arch. Neurol.
– volume: 281
  start-page: 22917
  year: 2006
  end-page: 22932
  ident: bib17
  article-title: Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit
  publication-title: J. Biol. Chem.
– volume: 86
  start-page: 4175
  year: 1989
  end-page: 4178
  ident: bib11
  article-title: Computer-simulation methods in human linkage analysis
  publication-title: Proc. Natl. Acad. Sci. USA
– volume: 388
  start-page: 839
  year: 1997
  end-page: 840
  ident: bib6
  article-title: Alpha-synuclein in Lewy bodies
  publication-title: Nature
– volume: 29
  start-page: 1661
  year: 2009
  end-page: 1669
  ident: bib14
  article-title: Requirement of RNA binding of mammalian eukaryotic translation initiation factor 4GI (eIF4GI) for efficient interaction of eIF4E with the mRNA cap
  publication-title: Mol. Cell. Biol.
– volume: 5
  start-page: 525
  year: 2006
  end-page: 535
  ident: bib3
  article-title: Epidemiology of Parkinson's disease
  publication-title: Lancet Neurol.
– volume: 136
  start-page: 731
  year: 2009
  end-page: 745
  ident: bib18
  article-title: Regulation of translation initiation in eukaryotes: Mechanisms and biological targets
  publication-title: Cell
– volume: 89
  start-page: 162
  year: 2011
  end-page: 167
  ident: bib5
  article-title: VPS35 Mutations in Parkinson Disease
  publication-title: Am. J. Hum. Genet.
– volume: 218
  start-page: 235
  year: 2009
  end-page: 246
  ident: bib7
  article-title: Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease
  publication-title: Exp. Neurol.
– volume: 8
  start-page: 711
  year: 2007
  end-page: 723
  ident: bib24
  article-title: Translation matters: Protein synthesis defects in inherited disease
  publication-title: Nat. Rev. Genet.
– volume: 181
  start-page: 293
  year: 2008
  end-page: 307
  ident: bib9
  article-title: eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy
  publication-title: J. Cell Biol.
– volume: 95
  start-page: 141
  year: 2003
  end-page: 156
  ident: bib16
  article-title: Conducting the initiation of protein synthesis: The role of eIF4G
  publication-title: Biol. Cell
– volume: 11
  start-page: 903
  year: 2009
  ident: 10.1016/j.ajhg.2011.08.009_bib10
  article-title: Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1900
– volume: 1170
  start-page: 615
  year: 2009
  ident: 10.1016/j.ajhg.2011.08.009_bib19
  article-title: Parkinson's disease: The dual hit theory revisited
  publication-title: Ann. N Y Acad. Sci.
  doi: 10.1111/j.1749-6632.2009.04365.x
– volume: 8
  start-page: 711
  year: 2007
  ident: 10.1016/j.ajhg.2011.08.009_bib24
  article-title: Translation matters: Protein synthesis defects in inherited disease
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg2142
– volume: 388
  start-page: 839
  year: 1997
  ident: 10.1016/j.ajhg.2011.08.009_bib6
  article-title: Alpha-synuclein in Lewy bodies
  publication-title: Nature
  doi: 10.1038/42166
– volume: 8
  start-page: 1150
  year: 2009
  ident: 10.1016/j.ajhg.2011.08.009_bib2
  article-title: Neuropathological assessment of Parkinson's disease: Refining the diagnostic criteria
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(09)70238-8
– volume: 218
  start-page: 235
  year: 2009
  ident: 10.1016/j.ajhg.2011.08.009_bib7
  article-title: Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease
  publication-title: Exp. Neurol.
  doi: 10.1016/j.expneurol.2009.03.006
– volume: 281
  start-page: 22917
  year: 2006
  ident: 10.1016/j.ajhg.2011.08.009_bib17
  article-title: Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M605418200
– volume: 466
  start-page: 637
  year: 2010
  ident: 10.1016/j.ajhg.2011.08.009_bib22
  article-title: Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
  publication-title: Nature
  doi: 10.1038/nature09191
– volume: 10
  start-page: 307
  year: 2009
  ident: 10.1016/j.ajhg.2011.08.009_bib21
  article-title: Molecular mechanisms of mTOR-mediated translational control
  publication-title: Nature reviews
  doi: 10.1038/nrm2672
– volume: 2
  start-page: ra36
  year: 2009
  ident: 10.1016/j.ajhg.2011.08.009_bib25
  article-title: Inhibition of mTOR signaling in Parkinson's disease prevents L-DOPA-induced dyskinesia
  publication-title: Sci. Signal.
  doi: 10.1126/scisignal.2000308
– volume: 15
  start-page: 1075
  year: 2000
  ident: 10.1016/j.ajhg.2011.08.009_bib8
  article-title: Linkage exclusion in French families with probable Parkinson' s disease
  publication-title: Mov. Disord.
  doi: 10.1002/1531-8257(200011)15:6<1075::AID-MDS1004>3.0.CO;2-2
– volume: 29
  start-page: 1661
  year: 2009
  ident: 10.1016/j.ajhg.2011.08.009_bib14
  article-title: Requirement of RNA binding of mammalian eukaryotic translation initiation factor 4GI (eIF4GI) for efficient interaction of eIF4E with the mRNA cap
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.01187-08
– volume: 86
  start-page: 4175
  year: 1989
  ident: 10.1016/j.ajhg.2011.08.009_bib11
  article-title: Computer-simulation methods in human linkage analysis
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.86.11.4175
– volume: 276
  start-page: 2045
  year: 1997
  ident: 10.1016/j.ajhg.2011.08.009_bib15
  article-title: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
  publication-title: Science
  doi: 10.1126/science.276.5321.2045
– volume: 12
  start-page: 1129
  year: 2009
  ident: 10.1016/j.ajhg.2011.08.009_bib23
  article-title: Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.2372
– volume: 1147
  start-page: 93
  year: 2008
  ident: 10.1016/j.ajhg.2011.08.009_bib20
  article-title: Oxidative stress in Parkinson's disease: A mechanism of pathogenic and therapeutic significance
  publication-title: Ann. N Y Acad. Sci.
  doi: 10.1196/annals.1427.023
– volume: 52
  start-page: 121
  year: 2001
  ident: 10.1016/j.ajhg.2011.08.009_bib12
  article-title: Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees
  publication-title: Hum. Hered.
  doi: 10.1159/000053366
– volume: 89
  start-page: 162
  year: 2011
  ident: 10.1016/j.ajhg.2011.08.009_bib5
  article-title: VPS35 Mutations in Parkinson Disease
  publication-title: Am. J. Hum. Genet.
  doi: 10.1016/j.ajhg.2011.06.001
– volume: 5
  start-page: 525
  year: 2006
  ident: 10.1016/j.ajhg.2011.08.009_bib3
  article-title: Epidemiology of Parkinson's disease
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(06)70471-9
– volume: 68
  start-page: 201
  year: 2010
  ident: 10.1016/j.ajhg.2011.08.009_bib4
  article-title: Genetic analysis of pathways to Parkinson disease
  publication-title: Neuron
  doi: 10.1016/j.neuron.2010.10.014
– volume: 181
  start-page: 293
  year: 2008
  ident: 10.1016/j.ajhg.2011.08.009_bib9
  article-title: eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy
  publication-title: J. Cell Biol.
  doi: 10.1083/jcb.200710215
– volume: 56
  start-page: 33
  year: 1999
  ident: 10.1016/j.ajhg.2011.08.009_bib1
  article-title: Diagnostic criteria for Parkinson disease
  publication-title: Arch. Neurol.
  doi: 10.1001/archneur.56.1.33
– volume: 21
  start-page: 557
  year: 2005
  ident: 10.1016/j.ajhg.2011.08.009_bib13
  article-title: MAP-O-MAT: Internet-based linkage mapping
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bti024
– volume: 136
  start-page: 731
  year: 2009
  ident: 10.1016/j.ajhg.2011.08.009_bib18
  article-title: Regulation of translation initiation in eukaryotes: Mechanisms and biological targets
  publication-title: Cell
  doi: 10.1016/j.cell.2009.01.042
– volume: 95
  start-page: 141
  year: 2003
  ident: 10.1016/j.ajhg.2011.08.009_bib16
  article-title: Conducting the initiation of protein synthesis: The role of eIF4G
  publication-title: Biol. Cell
  doi: 10.1016/S0248-4900(03)00031-5
– reference: 20671708 - Nature. 2010 Jul 29;466(7306):637-41
– reference: 9923759 - Arch Neurol. 1999 Jan;56(1):33-9
– reference: 19239892 - Cell. 2009 Feb 20;136(4):731-45
– reference: 16713924 - Lancet Neurol. 2006 Jun;5(6):525-35
– reference: 19686202 - Ann N Y Acad Sci. 2009 Jul;1170:615-22
– reference: 17680008 - Nat Rev Genet. 2007 Sep;8(9):711-23
– reference: 19622833 - Sci Signal. 2009;2(80):ra36
– reference: 19303005 - Exp Neurol. 2009 Aug;218(2):235-46
– reference: 19339977 - Nat Rev Mol Cell Biol. 2009 May;10(5):307-18
– reference: 19684592 - Nat Neurosci. 2009 Sep;12(9):1129-35
– reference: 2726769 - Proc Natl Acad Sci U S A. 1989 Jun;86(11):4175-8
– reference: 16766523 - J Biol Chem. 2006 Aug 11;281(32):22917-32
– reference: 21763482 - Am J Hum Genet. 2011 Jul 15;89(1):162-7
– reference: 18426977 - J Cell Biol. 2008 Apr 21;181(2):293-307
– reference: 11588394 - Hum Hered. 2001;52(3):121-31
– reference: 9197268 - Science. 1997 Jun 27;276(5321):2045-7
– reference: 20955928 - Neuron. 2010 Oct 21;68(2):201-6
– reference: 9278044 - Nature. 1997 Aug 28;388(6645):839-40
– reference: 19909913 - Lancet Neurol. 2009 Dec;8(12):1150-7
– reference: 19076434 - Ann N Y Acad Sci. 2008 Dec;1147:93-104
– reference: 15374870 - Bioinformatics. 2005 Feb 15;21(4):557-9
– reference: 19525934 - Nat Cell Biol. 2009 Jul;11(7):903-8
– reference: 12867079 - Biol Cell. 2003 May-Jun;95(3-4):141-56
– reference: 11104189 - Mov Disord. 2000 Nov;15(6):1075-83
– reference: 19114555 - Mol Cell Biol. 2009 Mar;29(6):1661-9
SSID ssj0011803
Score 2.488004
Snippet Genome-wide analysis of a multi-incident family with autosomal-dominant parkinsonism has implicated a locus on chromosomal region 3q26-q28. Linkage and disease...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 398
SubjectTerms Base Sequence
Binding sites
Biological and medical sciences
Chromosomes
Chromosomes, Human, Pair 3 - genetics
Cloning, Molecular
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
DNA Copy Number Variations
DNA Mutational Analysis
Eukaryotic Initiation Factor-4G - genetics
Flow Cytometry
Fundamental and applied biological sciences. Psychology
General aspects. Genetic counseling
Genetic Linkage
Genetics of eukaryotes. Biological and molecular evolution
Genotype
Genotype & phenotype
Humans
Immunoprecipitation
Medical genetics
Medical sciences
Mitochondria - physiology
Molecular and cellular biology
Molecular Sequence Data
Mutation
Mutation, Missense - genetics
Neurology
Parkinson Disease - genetics
Parkinson's disease
Pedigree
Protein Biosynthesis - genetics
Proteins
Title Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease
URI https://dx.doi.org/10.1016/j.ajhg.2011.08.009
https://www.ncbi.nlm.nih.gov/pubmed/21907011
https://www.proquest.com/docview/892059614
https://www.proquest.com/docview/889177892
https://www.proquest.com/docview/910786217
https://pubmed.ncbi.nlm.nih.gov/PMC3169825
Volume 89
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9QwDLfGJCQkNDE-y9gpD7yhas0laZpH2HbbkMbTkO4tSpqU3YS60-7ugf8eu2k7Do098No6auvYsV3_bAN8jN5prwMKrxIul4aLvPJVkctaV2bKm8Zpqne-_Faef5df52q-A8dDLQzBKvuzP53p3WndXznquXm0XCyoxreYonHX1PRMKEM9QYWsuiK--Zcxk8CrQgwuMFH3hTMJ4-Vurn_ct_EkUOLDxun50q2QZU2adfGQM_o3pvIPIzV7AXu9d8k-pw_Yh53YvoSnad7kr1dw0lmmhH5jFwQbopCbnV7M5Blnl5uUll-xRcu6gRgom4zKorsKMXaScjmv4Wp2enV8nvdjFPK6LMw6D74pnRcS1TmgNnoVVJAuThs_la70LvCoK2ei0N7VOspaanQMTIWRmIgmiDew29628R0wtP2Bl1q4qlFSl8bXvlYRGax8HUSIGfCBfbbuW4zTpIufdsCS3VhiuSWWWxp_WZgMPo1rlqnBxqPUatgVuyUmFi3Ao-smW1s4PooSz5JLnsHBsKe21-KVRWml6URcZsDGu6h-lFNxbbzdIEmF8S6J9b9J0CHTGDdyncHbJCP3T0d3TONbZqC3pGckoObf23faxXXXBFzw0mB0__4_GXIAz9LfcQLMfYDd9d0mHqJ7tfYTeHI255NOi34DytckMw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9QwDLfGEAIJIb4pg5EH3lC15pI2zSNsO-5gt6dDurcoaVJ2E-pO3N0D_z1203YcGnvgtXXU1rFju_7ZBngfnFVOeRTeXNhUai7S0pVZKitV6hGva6uo3nl2Xky-yS-LfLEHx30tDMEqu7M_nuntad1dOeq4ebRaLqnGNxuhcVfU9EzkWt6Bu-gNKNLO6eLTkErgZSZ6H5jIu8qZCPKylxffr_t4EirxZuv0cGXXyLM6Dru4yRv9G1T5h5UaP4ZHnXvJPsYveAJ7oXkK9-LAyV_P4KQ1TRH-xqaEG6KYm51Ox_IzZ7NtzMuv2bJh7UQMFE5GddFtiRg7icmc5zAfn86PJ2k3RyGtikxvUu_qwjohUZ89qqPLfe6lDaPajaQtnPU8qNLqIJSzlQqykgo9A11iKCaC9uIF7DdXTXgFDI2_54UStqxzqQrtKlflARmcu8oLHxLgPftM1fUYp1EXP0wPJrs0xHJDLDc0_zLTCXwY1qxih41bqfN-V8yOnBg0AbeuO9zZwuFRlHmWXPIEDvo9NZ0arw2KK40n4jIBNtxF_aOkim3C1RZJSgx4Sa7_TYIemcLAkasEXkYZuX46-mMK3zIBtSM9AwF1_9690ywv2i7gghcaw_vX_8mQd3B_Mp-dmbPp-dcDeBB_lRN67g3sb35uw1v0tTbusNWl35RDJmI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Translation+Initiator+EIF4G1+Mutations+in+Familial+Parkinson+Disease&rft.jtitle=American+journal+of+human+genetics&rft.au=Chartier-Harlin%2C+Marie-Christine&rft.au=Dachsel%2C+Justus+C&rft.au=Vilari%C3%B1o-G%C3%BCell%2C+Carles&rft.au=Lincoln%2C+Sarah+J&rft.date=2011-09-09&rft.pub=Cell+Press&rft.issn=0002-9297&rft.eissn=1537-6605&rft.volume=89&rft.issue=3&rft.spage=398&rft_id=info:doi/10.1016%2Fj.ajhg.2011.08.009&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=2459816781
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9297&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9297&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9297&client=summon